{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["genetic polymorphisms", "gestational hypertension", "guanylate cyclase 1 soluble alpha 3", "nitric oxide", "nitric oxide synthase 3", "nitrite", "preeclampsia", "pregnancy"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "38469120", "DateRevised": {"Year": "2024", "Month": "06", "Day": "08"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "26"}], "ELocationID": ["1293082", "10.3389/fgene.2024.1293082"], "Journal": {"ISSN": "1664-8021", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2024"}}, "Title": "Frontiers in genetics", "ISOAbbreviation": "Front Genet"}, "ArticleTitle": "Functional polymorphisms of <i>NOS3</i> and <i>GUCY1A3</i> affect both nitric oxide formation and association with hypertensive disorders of pregnancy.", "Pagination": {"StartPage": "1293082", "MedlinePgn": "1293082"}, "Abstract": {"AbstractText": ["Impaired nitric oxide (NO) formation may be associated with endothelial dysfunction and increased cardiovascular disease risk in preeclampsia (PE). Functional single-nucleotide polymorphisms (SNPs) of nitric oxide synthase 3 (<i>NOS3</i>) (rs3918226) and guanylate cyclase 1, soluble, alpha 3 (<i>GUCY1A3</i>) (rs7692387) increase susceptibility to the adverse consequences due to inadequate generation of NO by the endothelium. However, no previous study has examined whether these SNPs affect NO formation in healthy pregnancy and in gestational hypertension (GH) and PE. Here, we compared the alleles and genotypes of <i>NOS3</i> (rs3918226) and <i>GUCY1A3</i> (rs7692387) SNPs in normotensive pregnant women (NP, <i>n</i> = 153), in GH (<i>n</i> = 96) and PE (<i>n</i> = 163), and examined whether these SNPs affect plasma nitrite concentrations (a marker of NO formation) in these groups. We further examined whether the interaction among SNP genotypes is associated with GH and PE. Genotypes were determined using TaqMan allele discrimination assays, and plasma nitrite concentrations were determined by an ozone-based chemiluminescence assay. Multifactor dimensionality reduction was used to examine the interactions among SNP genotypes. Regarding <i>NOS3</i> rs3918226, the CT genotype (<i>p</i> = 0.046) and T allele (<i>p</i> = 0.020) were more frequent in NP than in GH, and GH patients carrying the CT+TT genotypes showed lower nitrite concentrations than NP carrying the CT+TT genotypes (<i>p</i> < 0.05). Regarding <i>GUCY1A3</i> rs7692387, the GA genotype (<i>p</i> = 0.013) and A allele (<i>p</i> = 0.016) were more frequent in PE than in NP, and NP women carrying the GG genotype showed higher nitrite concentrations than GH or PE patients carrying the GG genotype (<i>p</i> < 0.05). However, we found no significant interactions among genotypes for these functional SNPs to be associated with GH or PE. Our novel findings suggest that <i>NOS3</i> rs3918226 and <i>GUCY1A3</i> rs7692387 may affect NO formation and association with hypertensive disorders of pregnancy."], "CopyrightInformation": "Copyright \u00a9 2024 Pereira, Luizon, Palei, Tanus-Santos, Cavalli and Sandrim."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil."}], "LastName": "Pereira", "ForeName": "Daniela A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil."}, {"Identifier": [], "Affiliation": "Department of Biophysics and Pharmacology, Institute of Biosciences, Universidade Estadual Paulista (UNESP), Botucatu, Brazil."}], "LastName": "Luizon", "ForeName": "Marcelo R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, University of Mississippi Medical Center, Jackson, MS, United States."}], "LastName": "Palei", "ForeName": "Ana C", "Initials": "AC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeir\u00e3o Preto, Brazil."}], "LastName": "Tanus-Santos", "ForeName": "Jos\u00e9 E", "Initials": "JE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeir\u00e3o Preto, Brazil."}], "LastName": "Cavalli", "ForeName": "Ricardo C", "Initials": "RC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics and Pharmacology, Institute of Biosciences, Universidade Estadual Paulista (UNESP), Botucatu, Brazil."}], "LastName": "Sandrim", "ForeName": "Valeria C", "Initials": "VC"}], "GrantList": [{"GrantID": "K01 HL159032", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL148191", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "U54 GM115428", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Genet", "NlmUniqueID": "101560621", "ISSNLinking": "1664-8021"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Acog (2013). Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists' task force on hypertension in pregnancy. Obstet. Gynecol. 122 (5), 1122\u20131131. 10.1097/01.AOG.0000437382.03963.88", "ArticleIdList": ["10.1097/01.AOG.0000437382.03963.88", "24150027"]}, {"Citation": "Ahmed R., Dunford J., Mehran R., Robson S., Kunadian V. (2014). Pre-eclampsia and future cardiovascular risk among women: a review. J. Am. Coll. Cardiol. 63, 1815\u20131822. 10.1016/j.jacc.2014.02.529", "ArticleIdList": ["10.1016/j.jacc.2014.02.529", "24613324"]}, {"Citation": "Chappell L. C., Cluver C. A., Kingdom J., Tong S. (2021). Pre-eclampsia. Lancet 398, 341\u2013354. 10.1016/S0140-6736(20)32335-7", "ArticleIdList": ["10.1016/S0140-6736(20)32335-7", "34051884"]}, {"Citation": "Consortium G. T. (2015). Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648\u2013660. 10.1126/science.1262110", "ArticleIdList": ["10.1126/science.1262110", "PMC4547484", "25954001"]}, {"Citation": "De Miranda J. A., Lacchini R., Belo V. A., Lanna C. M., Sertorio J. T., Luizon M. R., et al. (2015). The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents. J. Hum. Hypertens. 29, 109\u2013114. 10.1038/jhh.2014.48", "ArticleIdList": ["10.1038/jhh.2014.48", "24943287"]}, {"Citation": "Denninger J. W., Marletta M. A. (1999). Guanylate cyclase and the.NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411, 334\u2013350. 10.1016/s0005-2728(99)00024-9", "ArticleIdList": ["10.1016/s0005-2728(99)00024-9", "10320667"]}, {"Citation": "Emdin C. A., Khera A. V., Klarin D., Natarajan P., Zekavat S. M., Nomura A., et al. (2018). Phenotypic consequences of a genetic predisposition to enhanced nitric oxide signaling. Circulation 137, 222\u2013232. 10.1161/CIRCULATIONAHA.117.028021", "ArticleIdList": ["10.1161/CIRCULATIONAHA.117.028021", "PMC5771958", "28982690"]}, {"Citation": "Forstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I., et al. (1994). Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23, 1121\u20131131. 10.1161/01.hyp.23.6.1121", "ArticleIdList": ["10.1161/01.hyp.23.6.1121", "7515853"]}, {"Citation": "Gauderman W. J. (2002). Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med. 21, 35\u201350. 10.1002/sim.973", "ArticleIdList": ["10.1002/sim.973", "11782049"]}, {"Citation": "Ghasemi A., Zahedi Asl S., Mehrabi Y., Saadat N., Azizi F. (2008). Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life Sci. 83, 326\u2013331. 10.1016/j.lfs.2008.06.010", "ArticleIdList": ["10.1016/j.lfs.2008.06.010", "18662705"]}, {"Citation": "Gui J., Andrew A. S., Andrews P., Nelson H. M., Kelsey K. T., Karagas M. R., et al. (2011). A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Ann. Hum. Genet. 75, 20\u201328. 10.1111/j.1469-1809.2010.00624.x", "ArticleIdList": ["10.1111/j.1469-1809.2010.00624.x", "PMC3057873", "21091664"]}, {"Citation": "Honigberg M. C., Chaffin M., Aragam K., Bhatt D. L., Wood M. J., Sarma A. A., et al. (2020). Genetic variation in cardiometabolic traits and medication targets and the risk of hypertensive disorders of pregnancy. Circulation 142, 711\u2013713. 10.1161/CIRCULATIONAHA.120.047936", "ArticleIdList": ["10.1161/CIRCULATIONAHA.120.047936", "PMC7436942", "32804569"]}, {"Citation": "Hutcheon J. A., Lisonkova S., Joseph K. S. (2011). Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 25, 391\u2013403. 10.1016/j.bpobgyn.2011.01.006", "ArticleIdList": ["10.1016/j.bpobgyn.2011.01.006", "21333604"]}, {"Citation": "Kessler T., Wobst J., Wolf B., Eckhold J., Vilne B., Hollstein R., et al. (2017). Functional characterization of the GUCY1A3 coronary artery disease risk locus. Circulation 136, 476\u2013489. 10.1161/CIRCULATIONAHA.116.024152", "ArticleIdList": ["10.1161/CIRCULATIONAHA.116.024152", "PMC5560301", "28487391"]}, {"Citation": "Li R., Lyn D., Lapu-Bula R., Oduwole A., Igho-Pemu P., Lankford B., et al. (2004). Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am. J. Hypertens. 17, 560\u2013567. 10.1016/j.amjhyper.2004.02.013", "ArticleIdList": ["10.1016/j.amjhyper.2004.02.013", "15233974"]}, {"Citation": "Lo C. C. W., Lo A. C. Q., Leow S. H., Fisher G., Corker B., Batho O., et al. (2020). Future cardiovascular disease risk for women with gestational hypertension: a systematic review and meta-analysis. J. Am. Heart Assoc. 9, e013991. 10.1161/JAHA.119.013991", "ArticleIdList": ["10.1161/JAHA.119.013991", "PMC7670531", "32578465"]}, {"Citation": "Loscalzo J. (2018). Nitric oxide signaling and atherothrombosis redux: evidence from experiments of nature and implications for therapy. Circulation 137, 233\u2013236. 10.1161/CIRCULATIONAHA.117.032901", "ArticleIdList": ["10.1161/CIRCULATIONAHA.117.032901", "29335284"]}, {"Citation": "Luizon M. R., Metzger I. F., Lacchini R., Tanus-Santos J. E. (2012). Endothelial nitric oxide synthase polymorphism rs3918226 associated with hypertension does not affect plasma nitrite levels in healthy subjects. Hypertension 59, e52. author reply e53. 10.1161/HYPERTENSIONAHA.112.194654", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.112.194654", "22547447"]}, {"Citation": "Luizon M. R., Palei A. C., Sandrim V. C., Amaral L. M., Machado J. S., Lacchini R., et al. (2014). Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J. 14, 535\u2013541. 10.1038/tpj.2014.26", "ArticleIdList": ["10.1038/tpj.2014.26", "24913092"]}, {"Citation": "Luizon M. R., Palei A. C. T., Belo V. A., Amaral L. M., Lacchini R., Duarte G., et al. (2017). Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J. 17, 427\u2013434. 10.1038/tpj.2016.35", "ArticleIdList": ["10.1038/tpj.2016.35", "27168100"]}, {"Citation": "Luizon M. R., Pereira D. A., Sandrim V. C. (2018). Pharmacogenomics of hypertension and preeclampsia: focus on gene-gene interactions. Front. Pharmacol. 9, 168. 10.3389/fphar.2018.00168", "ArticleIdList": ["10.3389/fphar.2018.00168", "PMC5835759", "29541029"]}, {"Citation": "Maynard S. E., Min J. Y., Merchan J., Lim K. H., Li J., Mondal S., et al. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649\u2013658. 10.1172/JCI17189", "ArticleIdList": ["10.1172/JCI17189", "PMC151901", "12618519"]}, {"Citation": "Mergia E., Friebe A., Dangel O., Russwurm M., Koesling D. (2006). Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J. Clin. Invest. 116, 1731\u20131737. 10.1172/JCI27657", "ArticleIdList": ["10.1172/JCI27657", "PMC1435723", "16614755"]}, {"Citation": "Metzger I. F., Luizon M. R., Lacchini R., Ishizawa M. H., Tanus-Santos J. E. (2013). Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in black subjects. Nitric Oxide 28, 33\u201338. 10.1016/j.niox.2012.10.002", "ArticleIdList": ["10.1016/j.niox.2012.10.002", "23069892"]}, {"Citation": "Moncada S., Higgs E. A. (2006). The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147 (Suppl. 1), S193\u2013S201. 10.1038/sj.bjp.0706458", "ArticleIdList": ["10.1038/sj.bjp.0706458", "PMC1760731", "16402104"]}, {"Citation": "Muniz L., Luizon M. R., Palei A. C., Lacchini R., Duarte G., Cavalli R. C., et al. (2012). eNOS tag SNP haplotypes in hypertensive disorders of pregnancy. DNA Cell Biol. 31, 1665\u20131670. 10.1089/dna.2012.1768", "ArticleIdList": ["10.1089/dna.2012.1768", "23062210"]}, {"Citation": "Pander J., Wessels J. A., Mathijssen R. H., Gelderblom H., Guchelaar H. J. (2010). Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle. Pharmacogenomics 11, 1011\u20131017. 10.2217/pgs.10.87", "ArticleIdList": ["10.2217/pgs.10.87", "20602619"]}, {"Citation": "Powe C. E., Levine R. J., Karumanchi S. A. (2011). Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123, 2856\u20132869. 10.1161/CIRCULATIONAHA.109.853127", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.853127", "PMC3148781", "21690502"]}, {"Citation": "Ritchie M. D., Motsinger A. A. (2005). Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics 6, 823\u2013834. 10.2217/14622416.6.8.823", "ArticleIdList": ["10.2217/14622416.6.8.823", "16296945"]}, {"Citation": "Rousset F. (2008). genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Mol. Ecol. Resour. 8, 103\u2013106. 10.1111/j.1471-8286.2007.01931.x", "ArticleIdList": ["10.1111/j.1471-8286.2007.01931.x", "21585727"]}, {"Citation": "Salvi E., Kutalik Z., Glorioso N., Benaglio P., Frau F., Kuznetsova T., et al. (2012). Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 59, 248\u2013255. 10.1161/HYPERTENSIONAHA.111.181990", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.111.181990", "PMC3272453", "22184326"]}, {"Citation": "Salvi E., Kuznetsova T., Thijs L., Lupoli S., Stolarz-Skrzypek K., D'avila F., et al. (2013). Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene. Hypertension 62, 844\u2013852. 10.1161/HYPERTENSIONAHA.113.01428", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.113.01428", "24019403"]}, {"Citation": "Sandrim V. C., Palei A. C., Cavalli R. C., Araujo F. M., Ramos E. S., Duarte G., et al. (2008a). eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9, 1467\u20131473. 10.2217/14622416.9.10.1467", "ArticleIdList": ["10.2217/14622416.9.10.1467", "18855535"]}, {"Citation": "Sandrim V. C., Palei A. C., Metzger I. F., Gomes V. A., Cavalli R. C., Tanus-Santos J. E. (2008b). Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension 52, 402\u2013407. 10.1161/HYPERTENSIONAHA.108.115006", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.108.115006", "18574068"]}, {"Citation": "Sandrim V. C., Palei A. C., Sertorio J. T., Cavalli R. C., Duarte G., Tanus-Santos J. E. (2010). Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Mol. Hum. Reprod. 16, 506\u2013510. 10.1093/molehr/gaq030", "ArticleIdList": ["10.1093/molehr/gaq030", "20457799"]}, {"Citation": "Sherry S. T., Ward M. H., Kholodov M., Baker J., Phan L., Smigielski E. M., et al. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311. 10.1093/nar/29.1.308", "ArticleIdList": ["10.1093/nar/29.1.308", "PMC29783", "11125122"]}, {"Citation": "Singhal P., Verma S. S., Ritchie M. D. (2023). Gene interactions in human disease studies-evidence is mounting. Annu. Rev. Biomed. Data Sci. 6, 377\u2013395. 10.1146/annurev-biodatasci-102022-120818", "ArticleIdList": ["10.1146/annurev-biodatasci-102022-120818", "37196359"]}, {"Citation": "Vanhoutte P. M. (2003). Endothelial control of vasomotor function: from health to coronary disease. Circ. J. 67, 572\u2013575. 10.1253/circj.67.572", "ArticleIdList": ["10.1253/circj.67.572", "12845177"]}, {"Citation": "Veiga E. C. A., Rocha P. R. H., Caviola L. L., Cardoso V. C., Costa F. D. S., Saraiva M., et al. (2021). Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis. Clin. (Sao Paulo) 76, e1999. 10.6061/clinics/2021/e1999", "ArticleIdList": ["10.6061/clinics/2021/e1999", "PMC7798130", "33503177"]}, {"Citation": "Williams P. J., Broughton Pipkin F. (2011). The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 25, 405\u2013417. 10.1016/j.bpobgyn.2011.02.007", "ArticleIdList": ["10.1016/j.bpobgyn.2011.02.007", "PMC3145161", "21429808"]}, {"Citation": "Wobst J., Schunkert H., Kessler T. (2018). Genetic alterations in the NO-cGMP pathway and cardiovascular risk. Nitric Oxide 76, 105\u2013112. 10.1016/j.niox.2018.03.019", "ArticleIdList": ["10.1016/j.niox.2018.03.019", "29601927"]}, {"Citation": "Wu P., Haththotuwa R., Kwok C. S., Babu A., Kotronias R. A., Rushton C., et al. (2017). Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ. Cardiovasc Qual. Outcomes 10, e003497. 10.1161/CIRCOUTCOMES.116.003497", "ArticleIdList": ["10.1161/CIRCOUTCOMES.116.003497", "28228456"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "12"}, {"Year": "2024", "Month": "2", "Day": "12"}, {"Year": "2024", "Month": "3", "Day": "12", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "3", "Day": "12", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "3", "Day": "12", "Hour": "3", "Minute": "49"}, {"Year": "2024", "Month": "2", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["38469120", "PMC10925623", "10.3389/fgene.2024.1293082", "1293082"]}}], "PubmedBookArticle": []}